keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
D-JBD19 TFA is a non-permeable peptide with neuroprotective effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | D-JBD19 TFA is a non-permeable peptide with neuroprotective effects. |
In vitro | D-JBD19 is a non-permeable peptide corresponding to dJNKi peptide [1]. |
In vivo | As compared with D-JNKI1, neuroprotective effects of D-JBD19 against middle cerebral artery occlusion. 15.7 ng of either D-JBD19 or D-JNKI1 or 1570 ng of D-JBD19 are injected i.c.v. just after the ischemia. Animals were killed 24 h later. 100 times more D-JBD19 is needed to provide protection than with D-JNKI1 [2]. |
Synonyms | D-JBD19 TFA |
Molecular Weight | 2364.58 |
Formula | C101H165F3N32O30 |
CAS No. | TP2162L |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
D-JBD19 TFA (954134-42-0 free base) TP2162L Others DJBD19 TFA (954134420 free base) D-JBD19 TFA D JBD19 TFA (954134 42 0 free base) 954134-42-0 954134-42-0 free base D-JBD-19 TFA (954134-42-0 free base) inhibitor inhibit